ICUI Stock Analysis: Buy, Sell, or Hold?
ICUI - ICU Medical Inc
$154.97
6.51 (4.39%)
▲
5d:
+4.13%
30d:
+18.77%
90d:
+23.76%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ICUI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ICUI shows positive signals but monitor for confirmation. Market pricing in 1.6% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ICUI shows positive signals but monitor for confirmation. Market pricing in 1.6% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$226.98
Based on 9.0% avg growth
INTRINSIC VALUE TODAY
$140.94
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICUI is currently trading at $154.97, which is considered extended relative to its 30-day fair value range of $134.37 to $146.38. The stock's valuation (Forward PE: 16.7) is in line with its historical norms (15.9). At these levels, the market is pricing in 1.6% annual earnings growth.
Technical Outlook: Technically, ICUI is showing sideways momentum. The price is approaching resistance at $155.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: ICUI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $172.50 (+11.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICUI is showing sideways momentum. The price is approaching resistance at $155.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: ICUI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $172.50 (+11.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$134.37 -
$146.38
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range (+5.9% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading below Wall St target ($172.50)
- BULLISH: Expecting earnings turnaround to 1.6% growth with -12.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$134.37 -
$146.38
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$135.05
Resistance Level
$155.06
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.66
Wall Street Target
$172.50
(+11.3%)
Revenue Growth (YoY)
-12.3%
Earnings Growth (YoY)
-23.8%
Profit Margin
2.1%
Valuation Premium vs History
+1.6% premium
PE vs Historical
16.7 vs 15.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.6%
(market-implied from PE analysis)
1-Year Target
$157.45
(+2%)
2-Year Target
$159.97
(+3%)
3-Year Target
$162.53
(+5%)
3-Yr Target (if PE normalizes)
(PE: 17→16)
PE COMPRESSION
$155.12
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 14.0%)
$300.46
(+94%)
Base:
(SPY PE: 16.7, Growth: 14.0%)
$229.81
(+48%)
Bear:
(PE: 14.2, Growth: 14.0%)
$195.34
(+26%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Forward PE: 17.95 | Forward EPS (Implied): $8.63
Bull Case
$187.13
(+21%)
Analyst growth 15.0%, PE expands to 18.9
Base Case
$154.97
(0%)
Market implied 0.0%, PE stable at 18.0
Bear Case
$118.55
(-24%)
Severe decline -15.0%, PE contracts to 16.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 04, 2026 9:45 AM ET
Data refreshes hourly during market hours. Next update: 10:45 AM
Data refreshes hourly during market hours. Next update: 10:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICUI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
